AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

OLMESARTAN MEDOXOMIL+HYDROCHLOROTHIAZIDE

10 registrations across 3 African markets— 2 active

Markets with OLMESARTAN MEDOXOMIL+HYDROCHLOROTHIAZIDE

Recent registrations

Brand / ProductMarketHolderStatusExpires
OLMI 40H
Tablet
🇰🇪KenyaKRISHNA CHEMISTS LTDactiveJan 2027
OLMECARD PLUS
Comprimé pelliculé / 20mg/25mg
🇹🇳TunisiaTHERAexpiredMar 2021
OLMECARD PLUS
Comprimé pelliculé / 20mg/12.5mg
🇹🇳TunisiaTHERAexpiredMar 2021
OLMECARD PLUS
Comprimé pelliculé / 40mg/25mg
🇹🇳TunisiaTHERAexpiredMar 2021
OLMECARD PLUS
Comprimé pelliculé / 40mg/12.5mg
🇹🇳TunisiaTHERAexpiredMar 2021
COOLMETEC
Comprimé pelliculé / 40 mg/12.5 mg
🇹🇳TunisiaDAIICHI SANKYO FRANCE S.A.SexpiredJan 2014
COOLMETEC
Comprimé pelliculé / 40 mg/25mg
🇹🇳TunisiaDAIICHI SANKYO FRANCE S.A.SexpiredJan 2014
COOLMETEC
Comprimé pelliculé / 20 mg/12.5 mg
🇹🇳TunisiaDAIICHI SANKYO FRANCE S.A.SexpiredApr 2007
COOLMETEC
Comprimé pelliculé / 20 mg/25mg
🇹🇳TunisiaDAIICHI SANKYO FRANCE S.A.SexpiredApr 2007
Olmesar H
Tablets
🇹🇿TanzaniaMacleods Pharmaceuticals Limitedactive

OLMESARTAN MEDOXOMIL+HYDROCHLOROTHIAZIDE in Africa — Regulatory Overview

OLMESARTAN MEDOXOMIL+HYDROCHLOROTHIAZIDE is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Kenya, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 2 (20%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.